Pablo Legorreta

About Pablo Legorreta

Pablo Legorreta is the founder of Royalty Pharma, the world's biggest acquirer of pharmaceutical royalty streams.

Royalty Pharma, which conducted an IPO in 2020, has collected revenue slices of blockbuster drugs like Humira, Imbruvica, Lyrica, and Xtandi.

A former investment banker at Lazard Fr'res, Legoretta started Royalty Pharma in New York as a private equity vehicle in 1996.

Legoretta is the sole owner of RP Management, the investment manager that oversees Royalty Pharma's $17 billion of assets.